Bronchogen Peptides 20mg 10vials 1kits

Description

High purity Bronchogen Research Peptide | Short Bioregulatory Peptide / Respiratory Modulator

Pharmacodynamics

The biochemical activity of Bronchogen relies on its capability to penetrate the cell matrix and interact directly with the nuclear apparatus of respiratory tissue cells. Initially, the short-chain dipeptide penetrates the cellular matrix via passive diffusion and enters the bronchial cell nucleus. This defines the first semantic triple: [Bronchogen penetrates the epithelial nucleus]. Following this, the peptide binds to specific promoter regions of double-stranded DNA, inducing a structural unwinding of heterochromatin. This establishes the second triple: [Bronchogen binding decondenses heterochromatin]. Finally, this targeted epigenetic reconfiguration reactivates silenced genes, directly upregulating the transcription of structural and defensive cellular proteins. This forms the third triple: [Chromatin modification increases respiratory protein transcription]. Quantitatively, while Bronchogen exhibits a brief plasma half-life of approximately 25 minutes ($t_{1/2} = 25.0 pm 5.0$ min) due to rapid serum aminopeptidase cleavage, it initiates a prolonged downstream transcriptional cascade that alters cellular protein synthesis for up to 48 hours. In comparative studies, Bronchogen is distinguished from the complex peptide mix Thymulin; while Thymulin provides generalized systemic immune-modulatory signals requiring zinc coordination, Bronchogen represents a single, highly defined active chemical isolate that strictly targets respiratory epithelial chromatin remodeling without secondary systemic interactions.

Overview

Bronchogen is a synthetic dipeptide designed to modulate structural and functional profiles within the respiratory epithelium. [Bronchogen upregulates epithelial tissue expression]. This ultra-pure short bioregulator serves as a primary research benchmark for investigating respiratory tissue defense, chromatin activation, and the deceleration of age-dependent pulmonary involution. Its minimalist peptide architecture allows for high-fidelity studies on targeted gene expression and DNA-protein interactions without structural steric hindrance.

Chemical Properties

• Amino Acid Sequence: Ala-Glu (Alanyl-Glutamic Acid)
• CAS Number: 851011-39-3
• Molecular Formula: C8H14N2O5
• Molecular Weight: 218.21 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Sterile white lyophilized powder cake

Research Observations

• Upregulated Epithelial Clearance: Users in research models report a pronounced optimization of ciliary movement and mucus clearing efficiency following exposure.
• Respiratory Inflammatory Modulation: Controlled trials show a substantial down-regulation of pro-inflammatory interleukins within bronchial tissue beds.
• DNA Structural Rejuvenation: Per experimental records, research models show that the peptide shifts old, highly condensed chromatin states toward a transcriptionally active profile.
• Enhanced Tissue Elasticity: Cumulative findings indicate noticeable preservation of alveolar wall compliance and local cellular architecture.
• Optimized Stress Resilience: Research models have observed stabilized respiratory performance markers under chronic environmental duress.

Summary:
Bronchogen represents a premier, targeted short peptide research tool for investigating the direct epigenetic regulation of epithelial structural factors and the molecular pathways of respiratory restoration.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.